What does Acclaro Medical do?
Acclaro Medical is a medical technology company based in Smithfield, RI, dedicated to developing innovative solutions for patient care, aesthetic, and surgical practices. The company focuses on creating advanced treatment options, including its flagship products UltraClear and AuraLux.
How much did they raise?
The company secured $23M in Series B funding, with Accelmed Partners leading the round and participation from 3E Bioventures Capital. This funding round is aimed at accelerating product growth and market expansion.
What are their plans for the money?
With the new funds, Acclaro Medical plans to accelerate the growth of its flagship products, expedite global market expansion, and invest in the development of new products. This expansion is expected to enhance the accessibility and effectiveness of its innovative medical solutions.
What have they achieved so far?
Acclaro Medical has made significant progress with its flagship product, UltraClear, a cold ablative fiber laser platform that offers a painless anti-aging solution without the need for topical numbing in most treatments. The technology is empowered by advanced systems such as 3DMIRACL and 3DIntelliPulse, which provide precise energy control for a range of skin rejuvenation outcomes.
